Ursolic acid

Mechanism of Action: Ursolic acid may help customers explore protein homeostasis modulation through autophagy activation, proteasome-related signaling, oxidative stress regulation, and inflammatory pathway control. It is suitable for studies evaluating how natural-product scaffolds influence clearance of unstable, damaged, or aggregation-prone proteins.

• Ternary Complex Optimization: Ursolic acid–based ligands can be explored in PROTAC designs to promote stable ternary complex formation with the chosen E3 ligase. Researchers can vary linker length, attachment position, and stereochemical constraints to maximize cooperative binding, enhance proximity-induced ubiquitination, and improve degradation potency of the target protein in cell-based degradation assays.

• E3 Ligase Recruitment Studies: Incorporating ursonic acid or ursolic acid derivatives into PROTAC architectures enables systematic evaluation of E3 ligase engagement. By comparing degradation profiles across different E3 ligases, investigators can identify which recruitment module yields efficient ubiquitin transfer, determine degradation selectivity, and map structure–activity relationships that govern productive engagement of the ubiquitin–proteasome pathway.

• Targeted Degradation Mechanism Mapping: Ursolic acid ligands can be used to build PROTACs that interrogate degradation mechanisms, including dependence on proteasome activity and ubiquitination. Experiments such as proteasome inhibition, NEDD8/ubiquitin pathway perturbation, and time-resolved Western blotting can clarify whether the construct drives rapid turnover, recycling, or partial degradation of the target protein.

• Structure–Activity Relationship Tuning: Ursolic acid’s scaffold offers multiple functionalization sites for PROTAC synthesis, supporting SAR-driven optimization. Researchers can systematically modify polarity, steric bulk, and linker chemistry to balance cell permeability with productive ternary complex formation, aiming to increase degradation efficiency while minimizing off-target engagement and improving degradation kinetics.

• Comparative Degrader Profiling: Ursolic acid–derived PROTACs can be benchmarked against non-degrading controls and alternative degrader formats to evaluate specificity. Comparative profiling across related targets and protein families helps determine degradation selectivity, identify degradation thresholds, and guide refinement of ligand orientation and linker geometry for robust, reproducible targeted protein degradation.

Ursolic acid is a BET bromodomain target ligand intended for use as the target-engaging component or reference ligand in PROTAC discovery workflows. Its known small-molecule recognition profile enables rational linker-vector evaluation and comparative degrader design. This molecule is described in detail below.

Structure: The structure of Ursolic acid is characterized by phenol or alcohol functionality. These features provide defined hydrogen-bonding, hydrophobic, and steric elements that can support affinity retention while enabling analogue-based linker-vector selection.

Reactivity: The hydroxy or phenolic motif can be considered for ether, carbonate, carbamate, or ester linker attachment after SAR verification. For PROTAC construction, the POI ligand can be paired with CRBN ligands such as thalidomide, pomalidomide, or lenalidomide analogues, VHL ligands such as VH032 derivatives, or less common IAP/MDM2/cIAP-recruiting ligands, with alkyl, PEG, piperazine, triazole, or amide linkers screened for ternary-complex formation. In practice, incorporation into PROTACs should begin from derivatives that preserve the reported binding pharmacophore, followed by systematic variation of linker length, polarity, rigidity, and exit-vector geometry to optimize target engagement, E3 recruitment, and cellular degradation readouts.